Epidermolysis bullosa and chronic wounds: A model for Wound Bed Preparation of fragile skin

Advances in Skin and Wound Care

Volumn 26, Issue 4, 2013, Pages 177-188

  Pope, Elena ^a   Lara Corrales, Irene ^a,b   Mellerio, Jemima E ^c   Martinez, Anna E ^d   Sibbald, Cathryn ^b   Sibbald, R Gary ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Dystrophic EB; EB simplex; Epidermolysis bullosa (EB); Junctional EB; Kindler syndrome; Skin diseases

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CONSENSUS DEVELOPMENT; EPIDERMOLYSIS BULLOSA; HUMAN; INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; WOUND HEALING;

CLINICAL PROTOCOLS; EPIDERMOLYSIS BULLOSA; HUMANS; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84876234641     PISSN: 15277941     EISSN: 15388654     Source Type: Journal    
DOI: 10.1097/01.ASW.0000428864.72412.b7     Document Type: Article

References (27)

1. Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-50.
2. Pope E, Lara-Corrales I, Mellerio J, et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol 2012;67:904-17.
3. Fivenson DP, Scherschun L, Choucair M, et al. Graftskin therapy in epidermolysis bullosa. J Am Acad Dermatol 2003;48:886-92.
4. Sibbald RG, Zuker R, Coutts P, Coelho S, Williamson D, Queen D. Using a dermal skin substitute in the treatment of chronic wounds secondary to recessive dystrophic epidermolysis bullosa: a case series. Ostomy Wound Manage 2005;51(11):22-46.
5. Sibbald RG, Orsted H, Schultz GS, Coutts P, Keast D; International Wound Bed Preparation Advisory Board; Canadian Chronic Wound Advisory Board. Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage 2003;49(11):23-51.
6. Kirshen C, Woo K, Ayello EA, Sibbald RG. Debridement: a vital component of wound bed preparation. Adv Skin Wound Care 2006;19:506-17.
7. Sibbald RG, Goodman L, Woo KY, et al. Special considerations in wound bed preparation 2011: an update. Adv Skin Wound Care 2011;24:415-36.
8. Kiuru M, Itoh M, Cairo MS, Christiano AM. Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 2010;28:371-82.
9. Wagner JE, Ishida-Yamamoto A, McGrath JA, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010;363:629-39.
10. Sibbald RG, Krasner DL, Lutz J. SCALE: Skin Changes at Life' s End: final consensus statement: October 1, 2009. Adv Skin Wound Care 2010;23:225-36.
11. Intong LR, Murrell DF. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol 2012;30:70-7.
12. Wong T, Gammon L, Liu L, et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008;128:2179-89.
13. Mellerio JE, Weiner M, Denyer JE, et al. Medical management of epidermolysis bullosa: proceedingsof the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. Int J Dermatol 2007;46:795-800.
14. Bolitho C, Xaymardan M, Lynch GW, Zoellner H. Vascularity during wound maturation correlates with fragmentation of serum albumin but not ceruloplasmin, transferrin, or haptoglobin. Wound Repair Regen 2010;18:211-22.
15. Posthauer ME. The role of nutrition in wound care. Adv Skin Wound Care 2012;25:62-3.
16. Keast DH, Fraser C. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases. Ostomy Wound Manage 2004;50(10):64-70.
17. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999;7:442-52.
18. Lara-Corrales I, Parkin PC, Stephens D, et al. The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: a feasibility trial. J Am Acad Dermatol 2012;66:264-70.
19. van Scheppingen C, Lettinga AT, Duipmans JC, Maathuis CG, Jonkman MF. Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews. Acta Derm Venereol 2008;88:143-50.
20. Woo K, Sibbald G, Fogh K, et al. Assessment and management of persistent (chronic) and total wound pain. Int Wound J 2008;5:205-15.
21. Sarzi-Puttini P, Vellucci R, Zuccaro SM, Cherubino P, Labianca R, Fornasari D. The appropriate treatment of chronic pain. Clinical Drug Investig 2012;32(Suppl 1):21-33.
22. Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009;60:203-11.
23. Keast DH, Bowering CK, Evans AW, Mackean GL, Burrows C, D'Souza L. MEASURE: a proposed assessment framework for developing best practice recommendations for wound assessment. Wound Repair Regen 2004;12(3 Suppl):S1-17.
24. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair Regen 2004;12:163-8.
25. Mellerio JE. Infection and colonization in epidermolysis bullosa. Dermatol Clin 2010;28:267-9.
26. Woo KY, Sibbald RG. A cross-sectional validation study of using NERDS and STONEES to assess bacterial burden. Ostomy Wound Manage 2009;55(8):40-8.
27. Hankin CS, Knispel J, Lopes M, Bronstone A, Maus E. Clinical and cost efficacy of advanced wound care matrices for venous ulcers. J Manage Care Pharm 2012;18:375-84.